Thomson Medical Group has restored its public float following the sale of 50 million shares, or 0.19% of the company’s share capital, via married deals on the Singapore Exchange Securities Trading (SGX-ST).
An internal verification by the company found that the public float had been restored to 10.15% of its issued share capital, excluding treasury shares, as at April 4. This represents 2,685,007,380 shares held by more than 8,000 public shareholders.
Accordingly, Thomson Medical is now in compliance with Rule 723 of SGX-ST’s listing manual.
The company’s public float first fell below 10% in September last year, and received three months to restore its public float.
Subsequently, the company received an additional one month to restore the public float before a final three month extension was granted in January after initially being rejected by SGX-ST.
Shares in Thomson Medical closed unchanged at 5.4 cents on April 4.
